GSK2194069
SIGMA/SML1259 - ≥97% (HPLC)
Synonym: (S)
CAS Number: 1332331-08-4
Empirical Formula (Hill Notation): C25H24N4O3
Molecular Weight: 428.48
MDL Number: MFCD28167807
Linear Formula: C25H24N4O3
Product Type: Chemical
| assay | ≥97% (HPLC) |
| color | white to light brown |
| form | powder |
| InChI | 1S/C25H24N4O3/c30-24(18-1 |
| InChI key | AQTPWCUIYUOEMG-INIZCTEOSA |
| Quality Level | 100 ![]() |
| SMILES string | O=C(C1CC1)N2CC[C@@H](CC(N |
| solubility | DMSO: 5 mg/mL, clear (warmed) |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | GSK2194069 is a fatty acid synthase (FAS) inhibitor. |
| Biochem/physiol Actions: | GSK2194069 is a fatty acid synthase (FAS) inhibitor. GSK2194069 is a potent and specific inhibitor of the β-ketoacyl reductase (KR) activity of hFAS with an IC50 of 7.7 ± 4.1 nM for the overall hFAS reaction. FAS is upregulated in some cancers, including prostate cancer. GSK2194069 was found to inhibit tumour growth in prostate cancer C42b cell xenografts generated in Nod-SCID-gamma mice. Cellular FAS inhibition reduced cell growth were also demonstrated in non-small-cell lung (A549) cancer cell lines with an average EC50 of 15 ± 0.5 nM. |
| Packaging: | 5, 25 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥97% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

